Interestingly, the effect of CBM-dependent NF-κB activation is not only confined to tumour growth (46) but also extends to affect the tumour’s microenvironment by stimulating the secretion of VEGF, interleukin-6 (IL-6), IL-8, and IL-1B. The gene discussed is CXCL8; the disease is neoplasm.